Authors:
Krystal, GW
Honsawek, S
Kiewlich, D
Liang, CX
Vasile, S
Sun, L
McMahon, G
Lipson, KE
Citation: Gw. Krystal et al., Indolinone tyrosine kinase inhibitors block kit activation and growth of small cell lung cancer cells, CANCER RES, 61(9), 2001, pp. 3660-3668
Authors:
Mendel, DB
Laird, AD
Smolich, BD
Blake, RA
Liang, CX
Hannah, AL
Shaheen, RM
Ellis, LM
Weitman, S
Shawver, LK
Cherrington, JM
Citation: Db. Mendel et al., Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent, ANTI-CAN DR, 15(1), 2000, pp. 29-41
Authors:
Sun, L
Tran, N
Liang, CX
Hubbard, S
Tang, F
Lipson, K
Schreck, R
Zhou, Y
McMahon, G
Tang, C
Citation: L. Sun et al., Identification of substituted 3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-1,3-dihydroindol-2-ones as growth factor receptor inhibitors for VEGF-R2 (Flk-1/KDR), FGF-R1, and PDGF-R beta tyrosine kinases, J MED CHEM, 43(14), 2000, pp. 2655-2663
Authors:
Kada, T
Obara, A
Watanabe, T
Miyata, S
Liang, CX
Machida, H
Kiso, K
Citation: T. Kada et al., Fabrication of refractive index distributions in polymer using a photochemical reaction, J APPL PHYS, 87(2), 2000, pp. 638-642
Authors:
Sun, L
Tran, N
Liang, CX
Tang, F
Rice, A
Schreck, R
Waltz, K
Shawver, LK
McMahon, G
Tang, C
Citation: L. Sun et al., Design, synthesis, and evaluations of substituted 3-[(3-or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGFreceptor tyrosine kinases, J MED CHEM, 42(25), 1999, pp. 5120-5130